GLOBAL-E ONLINE LTD. (GLBE) SEC News June 22, 2026, 20:14 UTC 0 1 comments Tamari Shahar 🔴 sold 1.5M shares (2 derivative) of Global-E Online Ltd. (GLBE) at $32.51 ($4.5M) Transaction Date: Jun 18, 2026 | Filing ID: 277527 Comment Full text
ORTHOFIX MEDICAL INC. (OFIX) SEC News June 22, 2026, 20:14 UTC 0 1 comments McPherron Aviva 🔴 sold 3.7K shares of Orthofix Medical Inc. (OFIX) at $9.38 Transaction Date: Jun 18, 2026 | Filing ID: 277526 Comment Full text
NEXTCURE, INC. (NXTC) SEC News June 22, 2026, 20:14 UTC 0 1 comments Borgman Anne Elizabeth 🟢 acquired 2.3K shares (1 derivative) of NextCure, Inc. (NXTC) at $2.02 Transaction Date: Jun 18, 2026 | Filing ID: 003048 Comment Full text
NEXTCURE, INC. (NXTC) SEC News June 22, 2026, 20:14 UTC 0 1 comments Webster Stephen W 🟢 acquired 2.3K shares (1 derivative) of NextCure, Inc. (NXTC) at $2.02 Transaction Date: Jun 18, 2026 | Filing ID: 003043 Comment Full text
NEXTCURE, INC. (NXTC) SEC News June 22, 2026, 20:14 UTC 0 1 comments KABAKOFF DAVID S 🟢 acquired 3.5K shares (1 derivative) of NextCure, Inc. (NXTC) at $2.02 Transaction Date: Jun 18, 2026 | Filing ID: 003044 Comment Full text
NEXTCURE, INC. (NXTC) SEC News June 22, 2026, 20:14 UTC 0 1 comments Houston John G 🟢 acquired 2.3K shares (1 derivative) of NextCure, Inc. (NXTC) at $2.02 Transaction Date: Jun 18, 2026 | Filing ID: 003046 Comment Full text
COREBRIDGE FINANCIAL, INC. (CRBG) SEC News June 22, 2026, 20:14 UTC 0 1 comments Director Lynch Christopher S. 🟢 acquired 6.6K shares of Corebridge Financial, Inc. (CRBG) Transaction Date: Jun 18, 2026 | Filing ID: 044635 Comment Full text
COREBRIDGE FINANCIAL, INC. (CRBG) SEC News June 22, 2026, 20:14 UTC 0 1 comments Director Leone Deborah R 🟢 acquired 6.6K shares of Corebridge Financial, Inc. (CRBG) Transaction Date: Jun 18, 2026 | Filing ID: 044634 Comment Full text
COREBRIDGE FINANCIAL, INC. (CRBG) SEC News June 22, 2026, 20:14 UTC 0 1 comments Director Bousa Edward Peter 🟢 acquired 6.6K shares of Corebridge Financial, Inc. (CRBG) Transaction Date: Jun 18, 2026 | Filing ID: 044632 Comment Full text
NAUTILUS BIOTECHNOLOGY, INC. (NAUT) SEC News June 22, 2026, 20:14 UTC 0 1 comments Director Posard Matthew L. 🟢 acquired 45.0K shares (1 derivative) of Nautilus Biotechnology, Inc. (NAUT) at $2.28 Transaction Date: Jun 18, 2026 | Filing ID: 000002 Comment Full text